| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The OptiMAL test detects both Plasmodium falciparum and P. vivax malaria infections. In this study, we evaluated the performance of the OptiMAL test at the Basic Health Units (BHUs) and the District Health Quarter (DHQ) Center in rural villages of Punjab, Pakistan that provide minimal health services. Two sets of blood specimens obtained from 930 suspected malaria patients attending these BHUs were tested at BHUs and the DHQ Center by microscopy and the OptiMAL test. At the BHUs, 231 (25%) of the patients were positive by microscopy and 278 (30%) patients tested positive by the OptiMAL test. At the DHQ Center, microscopic analysis of a second set of specimens from the same patients confirmed the malaria infection in 386 (42%) patients and the OptiMAL test result was positive in 300 (32%) patients. To determine the performance of OptiMAL test at the BHUs and the DHQ Center, all data were compared with microscopy results obtained at the DHQ Center. The OptiMAL test results for P. falciparum at the BHUs were comparable to those of the OptiMAL test at the DHQ Center. However, the sensitivity, positive predictive value (PPV), and negative predictive value (NPV) of the OptiMAL test were considerably lower for P. vivax infections than for P. falciparum infections, irrespective of whether the test was performed at the BHUs or at the DHQ Center (P. falciparum: sensitivity = 78–85%, PPV = 89–97%, NPV = 96–98%; P. vivax: sensitivity = 61–76%, PPV = 88–95%, NPV = 90–93%). The OptiMAL test also detected a number of false-positive and false-negative results at both the BHUs and the DHQ Center. The false-positive results ranged from 1% to 2%; however, the number of false-negative results was much higher (BHUs: P. falciparum = 22%, P. vivax = 39%; DHQ Center: P. falciparum = 15%, P. vivax = 24%). In conclusion, these results, when combined with other advantages of the OptiMAL test, suggest that this test can be used by relatively inexperienced persons to diagnose malaria infection in rural areas where facilities for microscopy are not available.
Received August 24, 2002. Accepted for publication December 23, 2002.
Acknowledgments: We thank the technical staff at the Basic Health Unit and District Health Quarter Centers for their assistance in testing specimens for malaria.
Financial support: This study was supported by a grant from Kuwait University (MI 109, MI 06/01).
Authors’ addresses: Jamshaid Iqbal and Nabila Khalid, Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110, Kuwait, E-mail: iqbal{at}hsc.kuniv.edu.kw. Arif Muneer and Mohammed A. Ahmed, Malaria Control Department, Lahore, Punjab, Pakistan.
This article has been cited by other articles:
|
|
 |
|
  S. W. Lee, K. Jeon, B. R. Jeon, and I. Park Rapid Diagnosis of Vivax Malaria by the SD Bioline Malaria Antigen Test When Thrombocytopenia Is Present J. Clin. Microbiol., March 1, 2008; 46(3): 939 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wongsrichanalai, M. J. Barcus, S. Muth, A. Sutamihardja, and W. H. Wernsdorfer A Review of Malaria Diagnostic Tools: Microscopy and Rapid Diagnostic Test (RDT) Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mueller, I. Betuela, M. Ginny, J. C. Reeder, and B. Genton The Sensitivity of the OptiMAL Rapid Diagnostic Test to the Presence of Plasmodium falciparum Gametocytes Compromises Its Ability To Monitor Treatment Outcomes in an Area of Papua New Guinea in which Malaria Is Endemic J. Clin. Microbiol., February 1, 2007; 45(2): 627 - 630. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
